Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Hemab Therapeutics Holdings, Inc. (COAG)

NASDAQ

$39.95

$-0.16

(-0.39%)

Pre-Market

Hemab Therapeutics Holdings, Inc. (COAG) Live Price Chart

Last updated: ⁦2026-09-16 09:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Hemab Therapeutics Holdings, Inc. (COAG) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector and is listed on NASDAQ. The stock is currently priced at $39.95, with a market capitalisation of $1.89B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $23.00 to $55.42. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$1.89B
Open	$40.11
Day's High	$55.42
Day's Low	$23.00
Previous Close	$40.11
Volume	25.00
Average Volume	381.05K
P/E Ratio	--
52-Week High	$55.42
52-Week Low	$23.00
Dividend Yield	--
Earnings Date	--

Hemab Therapeutics Holdings, Inc. (COAG) Pre-Market Stock Price

Hemab Therapeutics Holdings, Inc. (COAG) is trading at $39.95 in pre-market trading as of 2026-09-16 08:10:00, down 0.39% ($0.16) from the previous close of $40.11

Pre-market trading shows how investors are pricing COAG before the regular session opens. The current pre-market price is near the previous close, indicating cautious early trading sentiment.

Hemab Therapeutics Holdings, Inc. (COAG) 7-Day Stock Price Change

Over the past seven days, Hemab Therapeutics Holdings, Inc. (COAG) moved from $44.41 to $39.95, representing a decline of 10.04% ($4.46).

The stock traded between $38.79 and $46.20 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 378.50 thousand shares, up versus the previous seven-day period, indicating higher trading activity.

COAG 52-Week Price Position

Position in Range: 52.3%

52W Low$23.00

52W High$55.42

COAG is currently trading at $39.95, placing it 52.3% of the way from its 52-week low of $23.00 to its 52-week high of $55.42. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Hemab Therapeutics Holdings, Inc. (COAG)?

Hemab Therapeutics Holdings Inc is a clinical-stage biotechnology company developing therapies for the treatment of blood coagulation disorders. It focuses on discovering, developing, and commercializing treatments for conditions such as Glanzmann thrombasthenia, Factor VII deficiency, and von Willebrand disease. Its flagship candidate, sutacimig (HMB-001), is a bispecific antibody currently in clinical trials for the prophylactic treatment of Glanzmann thrombasthenia and Factor VII deficiency. The company has one operating segment, engaged in the research and development of prophylactic therapeutics for bleeding disorders.

Hemab Therapeutics Holdings, Inc. Information

Industry	BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Exchange	NASDAQ
Company Website	https://www.hemab.com

How to Buy Hemab Therapeutics Holdings, Inc. (COAG) Stock on MEXC

Eligible investors can buy real shares of Hemab Therapeutics Holdings, Inc. (COAG) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for COAG and Place Your Order

Open the RealStocks trading page and search for COAG. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Hemab Therapeutics Holdings, Inc. (COAG) stock price today?

Hemab Therapeutics Holdings, Inc. (COAG) is currently trading at $ 39.95, down 0.39% ($0.16) from the previous close of $ 40.11. Intraday prices update in real time during regular trading hours.

2.Is COAG stock going up or down today?

As of 2026-09-16 08:10:00, COAG is trading at $ 39.95, down 0.39% ($0.16) from its previous close of $ 40.11. The stock has traded between $ 23.00 and $ 55.42 during today’s regular session. Past price movements do not guarantee future results.

3.What is COAG pre-market price?

As of 2026-09-16 08:10:00, COAG is trading at $ 39.95 in pre-market trading, down 0.39% ($0.16) from the previous close of $ 40.11. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is COAG after-hours price?

As of 2026-09-16 08:10:00, COAG is trading at $ 40.11 in after-hours trading, down 0.01% ($0.01) from the regular-session close of $ 40.11. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is COAG stock trading now?

COAG trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does COAG sit relative to its 52-week high and low?

Over the past 52 weeks, COAG has traded between a low of $ 23.00 and a high of $ 55.42. At $ 39.95, the stock is positioned 52.3% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Hemab Therapeutics Holdings, Inc. in?

Hemab Therapeutics Holdings, Inc. (COAG) operates in the BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES) sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Hemab Therapeutics Holdings, Inc.'s market capitalisation and where is it listed?

Hemab Therapeutics Holdings, Inc. is listed on the NASDAQ exchange with a market capitalisation of $ 1.89B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is COAG valued in terms of P/E ratio and EPS?

COAG trades at a P/E ratio of --, based on trailing-twelve-month EPS of --. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Hemab Therapeutics Holdings, Inc. pay a dividend?

Hemab Therapeutics Holdings, Inc. pays an indicated annual cash dividend of -- per share, with a current dividend yield of --% based on the latest share price. Dividend policies are subject to change at the board's discretion.